Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

  1. Garassino, M.C.
  2. Gadgeel, S.
  3. Novello, S.
  4. Halmos, B.
  5. Felip, E.
  6. Speranza, G.
  7. Hui, R.
  8. Garon, E.B.
  9. Horinouchi, H.
  10. Sugawara, S.
  11. Rodriguez-Abreu, D.
  12. Reck, M.
  13. Cristescu, R.
  14. Aurora-Garg, D.
  15. Loboda, A.
  16. Lunceford, J.
  17. Kobie, J.
  18. Ayers, M.
  19. Piperdi, B.
  20. Pietanza, M.C.
  21. Paz-Ares, L.
Zeitschrift:
JTO Clinical and Research Reports

ISSN: 2666-3643

Datum der Publikation: 2023

Ausgabe: 4

Nummer: 1

Art: Artikel

DOI: 10.1016/J.JTOCRR.2022.100431 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus